C. Lewden, . The-mortality-working, and C. Group, All-cause mortality in treated HIV-infected adults with CD4 ?500/mm 3 compared with the general population: evidence from a large European observational cohort collaboration, Intl J of Epidemiology, vol.41, issue.2, pp.433-445

L. House, Select Committee on HIV and AIDS in the United Kingdom, HIV and AIDS in the United Kingdom ? Written Evidence A to Z, Memorandum by HIV Scotland (HAUK61, pp.131-157, 2016.

Z. Yin, A. Brown, and G. Hughes, HIV in the United Kingdom 2014 Report: data to end 2013, 2014.

F. Nakagawa, R. Lodwick, and C. Smith, Projected life expectancy of people with HIV according to timing of diagnosis, AIDS, vol.26, issue.3, pp.335-343, 2011.
DOI : 10.1097/QAD.0b013e32834dcec9

A. Mocroft, . The-mortality-working, and C. Group, Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE), PLoS Medicine, vol.160, issue.1, 2013.
DOI : 10.1371/journal.pmed.1001510.s005

A. Van-sighem, L. Gras, and P. Reiss, Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals, Seventeenth Conference on Retroviruses and Opportunistic Infections
DOI : 10.1097/QAD.0b013e32833a3946

H. British and . Association, BHIVA guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012, HIV Medicine, vol.13, pp.1-85, 2012.

A. Horban, R. Podlasin, and G. Cholewinska, Terms of care over persons infected with HIV: Recommendations PTN AIDS, Polish AIDS Scientific Society, 2015.

E. Beck, S. Mandalia, and G. Lo, Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006, PLoS ONE, vol.153, issue.11, p.20200, 1996.
DOI : 10.1371/journal.pone.0020200.t003

E. Beck, S. Mandalia, and R. Sangha, The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996???2008, PLoS ONE, vol.153, issue.suppl 4, p.27830, 1996.
DOI : 10.1371/journal.pone.0027830.t006

H. Krentz, M. Auld, and M. Gill, The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection, HIV Medicine, vol.89, issue.2, pp.93-98, 2004.
DOI : 10.1001/archinte.159.7.758

H. British and . Association, British Association of Sexual Health and HIV, British Infection Society. UK national guidelines for HIV testing, 2008.

R. Walensky, K. Freedberg, and M. Weinstein, Cost-Effectiveness of HIV Testing and Treatment in the United States, Clinical Infectious Diseases, vol.194, issue.RR-14, pp.248-254, 2007.
DOI : 10.1086/505147

G. Sanders, A. Bayoumi, and M. Holodniy, Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age, Annals of Internal Medicine, vol.148, issue.12, pp.889-903, 2008.
DOI : 10.7326/0003-4819-148-12-200806170-00002

A. Antinori, T. Coenen, and D. Costagiola, Late presentation of HIV infection: a consensus definition, HIV Medicine, vol.47, issue.(S, pp.61-65, 2011.
DOI : 10.1111/j.1468-1293.2010.00857.x

B. Suligoi, A. Zucchetto, and E. Grande, Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy, BMC Infectious Diseases, vol.35, issue.9939, 2015.
DOI : 10.1097/QAI.0000000000000184

K. Bhaskaran, O. Hamouda, and M. Sannes, Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population, JAMA, vol.300, issue.1, pp.51-59, 2008.
DOI : 10.1001/jama.300.1.51

J. Yombi, C. Jonckheere, A. Vincent, and D. Wilmes, Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre, Acta Clinica Belgica, vol.49, issue.17, p.2014
DOI : 10.1089/jwh.2010.2655

K. High, M. Brennan-ing, and D. Clifford, HIV and Aging, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.60, issue.1, pp.1-18, 2012.
DOI : 10.1097/QAI.0b013e31825a3668

URL : http://pdfs.journals.lww.com/jaids/2012/07011/HIV_and_Aging___State_of_Knowledge_and_Areas_of.1.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1504774542271;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdas5DLZfxK7f4AHiDIN1SXPmASvfict39xNo8OqD59/U=;hash|TmwpzSlqLraRPZwd+oxbFA==

J. Mellors, A. Munoz, and J. Giorgi, Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-954, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003

M. Egger, M. May, and G. Chene, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, The Lancet, vol.360, issue.9327, pp.119-129, 2002.
DOI : 10.1016/S0140-6736(02)09411-4

A. Sasse, B. Research, and A. Hiv-consortium, Late presentation to HIV testing is overestimated when based on the consensus definition, HIV Medicine, vol.14, issue.Suppl 1, pp.231-234, 2016.
DOI : 10.1097/00002030-200309050-00005

W. Tse, Y. W. Huang, and W. , A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes, ClinicoEconomics and Outcomes Research, vol.7, pp.431-439, 2015.
DOI : 10.2147/CEOR.S85535

M. Margaret, G. Mark, D. Valerie, P. Kholoud, P. Frank et al., Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study, BMJ, vol.343, 2011.

. Murray and J. Christopher, Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990???2013: a systematic analysis for the Global Burden of Disease Study 2013, The Lancet, vol.384, issue.9947, pp.9947-1005, 2014.
DOI : 10.1016/S0140-6736(14)60844-8

M. Wolbers, Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy???The CASCADE Collaboration: A Collaboration of 23 Cohort Studies, PLoS Medicine, vol.5, issue.2, p.1000239, 2010.
DOI : 10.1371/journal.pmed.1000239.s001

F. Nakagawa, M. May, and A. Phillips, Life expectancy living with HIV, Current Opinion in Infectious Diseases, vol.26, issue.1, pp.17-25, 2013.
DOI : 10.1097/QCO.0b013e32835ba6b1

URL : http://pdfs.journals.lww.com/co-infectiousdiseases/2013/02000/Life_expectancy_living_with_HIV___recent_estimates.4.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1506848920051;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdAuWkMXS2W6M0m7gHhtVI5CSer9LdFwFhaO+G8EyZmAdn11PqKWd01cCN9hUKK/Eu;hash|RN/nF/q2gRuiehBtLLHwiQ==

A. J. Rodger, Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population, AIDS, vol.27, issue.6, pp.973-979, 2013.
DOI : 10.1097/QAD.0b013e32835cae9c

F. Nakagawa, Projected life expectancy of people with HIV according to timing of diagnosis, AIDS, vol.26, issue.3, pp.335-343, 2012.
DOI : 10.1097/QAD.0b013e32834dcec9

B. Woods, Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research, Value in Health, vol.19, issue.8, 2015.
DOI : 10.1016/j.jval.2016.02.017

H. Treasury, The Green Book. Appraisal and evaluation in central government. London: The Stationery Office, 2011.

N. Poland, Rights of the child ? patient financing benefits for children ? patients, 2014.

R. Smith, V. Delpech, and A. Brown, HIV transmission and high rates of late diagnoses among adults aged 50 years and over, AIDS, vol.24, issue.13, pp.2109-2115, 2010.
DOI : 10.1097/QAD.0b013e32833c7b9c

N. Poland, Comprehensive outpatient specialist care over patient infected with HIV, treated drugs retroviral (arv) -(kaos-hiv), rules for implementation, Annex 3 part d to Ordinance No, President of the National Health Fund, p.17, 2013.

. Sullivan, Budget Impact Analysis???Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force, Value in Health, vol.17, issue.1, 2013.
DOI : 10.1016/j.jval.2013.08.2291

E. J. Beck, S. Mandalia, and R. Sangha, The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996???2008, PLoS ONE, vol.153, issue.suppl 4, p.27830, 1996.
DOI : 10.1371/journal.pone.0027830.t006

P. Farnham, S. Sansom, and A. Hutchinson, How Much Should We Pay for a New HIV Diagnosis? A Mathematical Model of HIV Screening in US Clinical Settings, Medical Decision Making, vol.60, issue.24, pp.459-69, 2012.
DOI : 10.1001/jama.300.5.520

S. Zdrowotnej, Cennik centralnego laboratorium analitycznego, Hospital of Infectious Diseases in Warsaw, 2015.

F. Lin, P. Farnham, and R. Shrestha, Cost Effectiveness of HIV Prevention Interventions in the US, American Journal of Preventive Medicine, 2016.

B. Schackman, S. Goldie, and K. Freedberg, Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS, Medical Decision Making, vol.36, issue.1, pp.27-38, 2002.
DOI : 10.1001/jama.283.3.381

. Minister and . Health, Antiretroviral treatment of people living with HIV in Poland for the years, HEALTH PROGRAM, 2012.

J. Appleby, N. Devlin, and D. Parkin, Searching for cost effectiveness thresholds in the NHS, Health Policy, vol.91, issue.3, pp.239-245, 2009.
DOI : 10.1016/j.healthpol.2008.12.010

. Email-vzah@outcomesresearch, ca Patients 50+ age group: Late Detected Linear Regression: Poland, Patient age 50+, late HIV detected. Scatter Diagram (Predicted Y, Median Ranks vs. YEAR )